Information on applying for licences, drug submission requirements, clinical trials and selling veterinarian drugs.

Zyn nicotine pouches loved by young people for their appetite-suppressing effects have officially been approved in the US. The FDA said it found the pouches were a safer alternative to cigarettes ...

In a separate act passed in 2024, California moved to ban six of the nine FDA-approved artificial food dyes in public school food and drinks by 2027. Worried one of your favorite foods will be ...

The Food and Drug Administration on Thursday authorized the popular Zyn nicotine pouches for sale in the U.S., after studies by the agency determined Philip Morris International’s nicotine ...

In a separate act passed in 2024, California moved to ban six of the nine FDA-approved artificial food dyes in public school food and drinks by 2027. The bill did not include Red No. 3.

Red Dye No. 3, or erythrosine, is a synthetic red food dye once popular in candies and cakes. The ... [+] FDA bans Red Dye No. 3 under the Delaney Clause, citing cancer risks observed in lab ...

Approval has been given for the first UK launch of a traditional "vertical" rocket. The critical clearance from the air safety regulator has taken the country a step closer to seeing its first ...

Johnson & Johnson JNJ has initiated a rolling submission with the FDA seeking approval for TAR-200, its investigational drug-device combination to treat certain patients with non-muscle invasive ...

Officials cited a statute known as the Delaney Clause, which requires FDA to ban any additive found to cause cancer in people or animals. The dye is known as erythrosine, FD&C Red No. 3 or Red 3. The ...

nor are they 'FDA approved'". "There is no safe tobacco product," the agency said. "Youth should not use tobacco products and adults who do not use tobacco products should not start." On Wednesday ...

Visible healing of the intestinal lining was observed in 46% of subjects treated with the therapy. Credit: SewCreamStudio/Shutterstock. Eli Lilly has received ...

In 2024, the U.S. Food and Drug Administration (FDA) approved 50 new molecular entities, with 24 designated as first-in-class – will 2025 do better? For instance, cobenfy is the first new ...